Contents
  • Genetic Predispositions
  • Concurrent Medications
  • Personal Health Factors

Who Is Most at Risk for Statin Muscle Pain?

Who Is Most at Risk for Statin Muscle Pain?

Identifying Risk Factors

Statins are effective at lowering cholesterol, but they can cause muscle pain in some individuals. Learn about the risk factors that increase susceptibility to these side effects.
Contents
  • Genetic Predispositions
  • Concurrent Medications
  • Personal Health Factors

Genetic Predispositions

Genetic factors can significantly increase the risk of muscle pain from statins. Variants in the SLCO1B1 gene, which affects statin metabolism, are linked to higher risk. Understanding your genetic makeup can help tailor statin therapy to minimize side effects.

Concurrent Medications

Taking other medications that inhibit statin metabolism can increase muscle pain risk. Drugs that inhibit the CYP3A4 enzyme, such as certain antibiotics and antifungals, are known to increase this risk. Managing these interactions is crucial for minimizing side effects.
Factors increasing risk of muscle pain from statins, including genetic variants and concurrent medications that affect statin metabolism.

Personal Health Factors

Certain health conditions, like liver disease, kidney disease, and hypothyroidism, can increase the likelihood of experiencing statin muscle pain. Age, gender, and body composition also play roles, with older adults and women being more susceptible.

FAQs

What genetic factors increase statin muscle pain risk?

Variants in the SLCO1B1 gene increase risk.

How do other medications affect statin side effects?

They can inhibit statin metabolism, increasing risk.

Who is most susceptible to statin muscle pain?

Older adults, women, and those with certain health conditions.

Key Takeaways

Understanding risk factors for statin muscle pain can lead to better management and prevention strategies.
Concerned about your risk for statin muscle pain? Discuss with Doctronic today!
Additional References
  1. Brunham LR, Baker S, Mammen A, et al. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence. Cardiovasc Res 2018; 114:1073.
  2. Voora D, Shah SH, Spasojevic I, et al. The SLCO1B1*5 genetic variant is associated with statin-induced side effects. J Am Coll Cardiol 2009; 54:1609.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.